Lipoprotein(a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease results from the NHLBI family heart study

Paul N. Hopkins, Steven Hunt, Pamela J. Schreiner, John H. Eckfeldt, Ingrid B. Borecki, Curtis R. Ellison, Roger R. Williams, Kimberly D. Siegmund

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Background: A positive interaction between high plasma lipoprotein(a) [Lp(a)] and unfavorable plasma lipid levels has been reported to result in very high risk for premature coronary artery disease (CAD). We further examined this issue for men and women with early onset CAD. We also examined potential interactions betweeh Lp(a) and non-lipid risk factors. Methods and results: In 338 men and women with early onset CAD (most with a positive family history of early CAD) and 480 general population controls, we measured Lp(a), lipids and other risk factors. In univariate analysis, relative odds for CAD was 1.7 (P = 0.002) for plasma Lp(a) > 50 mg/dl. Elevated Lp(a) level was found to interact with adjusted plasma total/high density lipoprotein (HDL) cholesterol such that when Lp(a) was over 50 mg/dl and adjusted plasma total/HDL cholesterol > 5.8, relative odds for CAD were 8.0-9.6 (P < 0.0001) in multiple logistic regression. Non-lipid risk factors were generally found to multiply the risk associated with Lp(a) (as predicted by logistic regression) without evidence for interaction. Conclusions: We find evidence that Lp(a) does interact positively with adjusted plasma total/HDL cholesterol ratio. Aggressive risk factor intervention, especially for lipids, in those with elevated Lp(a) therefore appears indicated.

Original languageEnglish
Pages (from-to)333-345
Number of pages13
JournalAtherosclerosis
Volume141
Issue number2
DOIs
Publication statusPublished - 1 Dec 1998
Externally publishedYes

Fingerprint

National Heart, Lung, and Blood Institute (U.S.)
Lipoprotein(a)
Coronary Artery Disease
Lipids
HDL Cholesterol
Logistic Models
Odds Ratio
Population Control

Keywords

  • Case-control studies
  • Coronary heart disease
  • Genetics
  • Lipoprotein(a)
  • Plasma cholesterol
  • Risk factors

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Lipoprotein(a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease results from the NHLBI family heart study. / Hopkins, Paul N.; Hunt, Steven; Schreiner, Pamela J.; Eckfeldt, John H.; Borecki, Ingrid B.; Ellison, Curtis R.; Williams, Roger R.; Siegmund, Kimberly D.

In: Atherosclerosis, Vol. 141, No. 2, 01.12.1998, p. 333-345.

Research output: Contribution to journalArticle

Hopkins, Paul N. ; Hunt, Steven ; Schreiner, Pamela J. ; Eckfeldt, John H. ; Borecki, Ingrid B. ; Ellison, Curtis R. ; Williams, Roger R. ; Siegmund, Kimberly D. / Lipoprotein(a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease results from the NHLBI family heart study. In: Atherosclerosis. 1998 ; Vol. 141, No. 2. pp. 333-345.
@article{17346515c2214687a064927ef49c738e,
title = "Lipoprotein(a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease results from the NHLBI family heart study",
abstract = "Background: A positive interaction between high plasma lipoprotein(a) [Lp(a)] and unfavorable plasma lipid levels has been reported to result in very high risk for premature coronary artery disease (CAD). We further examined this issue for men and women with early onset CAD. We also examined potential interactions betweeh Lp(a) and non-lipid risk factors. Methods and results: In 338 men and women with early onset CAD (most with a positive family history of early CAD) and 480 general population controls, we measured Lp(a), lipids and other risk factors. In univariate analysis, relative odds for CAD was 1.7 (P = 0.002) for plasma Lp(a) > 50 mg/dl. Elevated Lp(a) level was found to interact with adjusted plasma total/high density lipoprotein (HDL) cholesterol such that when Lp(a) was over 50 mg/dl and adjusted plasma total/HDL cholesterol > 5.8, relative odds for CAD were 8.0-9.6 (P < 0.0001) in multiple logistic regression. Non-lipid risk factors were generally found to multiply the risk associated with Lp(a) (as predicted by logistic regression) without evidence for interaction. Conclusions: We find evidence that Lp(a) does interact positively with adjusted plasma total/HDL cholesterol ratio. Aggressive risk factor intervention, especially for lipids, in those with elevated Lp(a) therefore appears indicated.",
keywords = "Case-control studies, Coronary heart disease, Genetics, Lipoprotein(a), Plasma cholesterol, Risk factors",
author = "Hopkins, {Paul N.} and Steven Hunt and Schreiner, {Pamela J.} and Eckfeldt, {John H.} and Borecki, {Ingrid B.} and Ellison, {Curtis R.} and Williams, {Roger R.} and Siegmund, {Kimberly D.}",
year = "1998",
month = "12",
day = "1",
doi = "10.1016/S0021-9150(98)00174-9",
language = "English",
volume = "141",
pages = "333--345",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Lipoprotein(a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease results from the NHLBI family heart study

AU - Hopkins, Paul N.

AU - Hunt, Steven

AU - Schreiner, Pamela J.

AU - Eckfeldt, John H.

AU - Borecki, Ingrid B.

AU - Ellison, Curtis R.

AU - Williams, Roger R.

AU - Siegmund, Kimberly D.

PY - 1998/12/1

Y1 - 1998/12/1

N2 - Background: A positive interaction between high plasma lipoprotein(a) [Lp(a)] and unfavorable plasma lipid levels has been reported to result in very high risk for premature coronary artery disease (CAD). We further examined this issue for men and women with early onset CAD. We also examined potential interactions betweeh Lp(a) and non-lipid risk factors. Methods and results: In 338 men and women with early onset CAD (most with a positive family history of early CAD) and 480 general population controls, we measured Lp(a), lipids and other risk factors. In univariate analysis, relative odds for CAD was 1.7 (P = 0.002) for plasma Lp(a) > 50 mg/dl. Elevated Lp(a) level was found to interact with adjusted plasma total/high density lipoprotein (HDL) cholesterol such that when Lp(a) was over 50 mg/dl and adjusted plasma total/HDL cholesterol > 5.8, relative odds for CAD were 8.0-9.6 (P < 0.0001) in multiple logistic regression. Non-lipid risk factors were generally found to multiply the risk associated with Lp(a) (as predicted by logistic regression) without evidence for interaction. Conclusions: We find evidence that Lp(a) does interact positively with adjusted plasma total/HDL cholesterol ratio. Aggressive risk factor intervention, especially for lipids, in those with elevated Lp(a) therefore appears indicated.

AB - Background: A positive interaction between high plasma lipoprotein(a) [Lp(a)] and unfavorable plasma lipid levels has been reported to result in very high risk for premature coronary artery disease (CAD). We further examined this issue for men and women with early onset CAD. We also examined potential interactions betweeh Lp(a) and non-lipid risk factors. Methods and results: In 338 men and women with early onset CAD (most with a positive family history of early CAD) and 480 general population controls, we measured Lp(a), lipids and other risk factors. In univariate analysis, relative odds for CAD was 1.7 (P = 0.002) for plasma Lp(a) > 50 mg/dl. Elevated Lp(a) level was found to interact with adjusted plasma total/high density lipoprotein (HDL) cholesterol such that when Lp(a) was over 50 mg/dl and adjusted plasma total/HDL cholesterol > 5.8, relative odds for CAD were 8.0-9.6 (P < 0.0001) in multiple logistic regression. Non-lipid risk factors were generally found to multiply the risk associated with Lp(a) (as predicted by logistic regression) without evidence for interaction. Conclusions: We find evidence that Lp(a) does interact positively with adjusted plasma total/HDL cholesterol ratio. Aggressive risk factor intervention, especially for lipids, in those with elevated Lp(a) therefore appears indicated.

KW - Case-control studies

KW - Coronary heart disease

KW - Genetics

KW - Lipoprotein(a)

KW - Plasma cholesterol

KW - Risk factors

UR - http://www.scopus.com/inward/record.url?scp=0032401554&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032401554&partnerID=8YFLogxK

U2 - 10.1016/S0021-9150(98)00174-9

DO - 10.1016/S0021-9150(98)00174-9

M3 - Article

C2 - 9862182

AN - SCOPUS:0032401554

VL - 141

SP - 333

EP - 345

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 2

ER -